Tabi Tablets – Bicalutamide for Prostate Cancer Treatment
Looking for information about Tabi Tablets 50mg and 150mg? Tabi Tablets contain Bicalutamide, an anti-androgen medication used in the management of prostate cancer. Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information and international supply enquiries for healthcare businesses and pharmaceutical distributors.
This guide covers Tabi Tablets' composition, medical uses, potential benefits, side effects and important safety information for readers in the United States.
Tabi Tablets – Product Information
Tabi Tablets contain Bicalutamide, an androgen receptor inhibitor that helps manage prostate cancer by blocking the effects of male hormones, particularly testosterone, on prostate cancer cells.
Available Product Strengths:
Tabi Tablets 50mg – Bicalutamide 50mg
Tabi Tablets 150mg – Bicalutamide 150mg
Drug Category: Anti-androgen / Anticancer Medicine
Dosage Form: Oral Tablets
Therapeutic Area: Oncology
Active Ingredient: Bicalutamide
Medical Uses and Benefits of Tabi Tablets
Bicalutamide works by blocking androgen receptors, reducing the ability of male hormones to stimulate prostate cancer cell growth.
Potential therapeutic benefits include:
Prostate Cancer Management: Bicalutamide 50mg is indicated in the United States in combination with a luteinizing hormone-releasing hormone (LHRH) analogue for metastatic prostate cancer.
Hormonal Action: It blocks the effects of testosterone on prostate cancer cells.
Androgen Receptor Inhibition: It helps reduce hormonal stimulation of cancer cells.
Combination Therapy: It can be used alongside other prescribed hormonal treatments as part of an oncology treatment plan.
The 150mg strength has been studied in clinical settings; however, daily bicalutamide 150mg is not FDA-approved in the United States, either as monotherapy or in combination with other treatments.
Possible Side Effects of Tabi Tablets
Like other prescription oncology medicines, Bicalutamide may cause side effects. Commonly reported reactions include:
Hot flashes and excessive sweating
Breast tenderness or enlargement
Nausea and abdominal discomfort
Weakness and fatigue
Constipation or diarrhoea
Anaemia
Swelling in the legs or ankles
Reduced sexual desire
Important Safety Information: Bicalutamide may cause serious liver injury. Patients require appropriate liver-function monitoring. Yellowing of the skin or eyes, dark urine, severe abdominal pain or unusual fatigue requires prompt medical assessment.
Patients should inform their healthcare provider about existing medical conditions and all medicines they take, particularly anticoagulants.
Tabi Tablets for the US Pharmaceutical Market
Healthcare professionals, pharmaceutical distributors and procurement organisations researching Bicalutamide tablets should verify product registration, manufacturing quality, labelling and applicable FDA requirements before purchasing or importing.
For the US market, the FDA-approved indication and dosage must be distinguished from products or strengths marketed in other countries. Product availability does not establish FDA approval.
Frequently Asked Questions (FAQs)
1. What are Tabi Tablets used for?
Tabi Tablets contain Bicalutamide, which is used in the treatment of prostate cancer under medical supervision.
2. What strengths of Tabi Tablets are available?
The product range discussed here includes 50mg and 150mg strengths.
3. What is the active ingredient in Tabi Tablets?
The active pharmaceutical ingredient is Bicalutamide.
4. Can Tabi Tablets cause side effects?
Yes. Possible side effects include hot flashes, breast tenderness, nausea, fatigue and liver-related complications.
5. Are Tabi Tablets FDA-approved in the USA?
Bicalutamide 50mg has an FDA-approved indication for use with an LHRH analogue in metastatic prostate cancer. The 150mg daily regimen is not FDA-approved.
Contact Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical company serving international pharmaceutical business enquiries.
For product specifications, manufacturing documentation, export enquiries and wholesale supply information regarding Tabi Tablets 50mg and 150mg, contact Cordium Pharmaceuticals Pvt Ltd.
Medical Disclaimer: This article is intended for educational and pharmaceutical product-information purposes only. Tabi Tablets are prescription medicines and must be used under qualified medical supervision. This content does not replace professional medical advice or establish US FDA approval or commercial availability.
Looking for information about Tabi Tablets 50mg and 150mg? Tabi Tablets contain Bicalutamide, an anti-androgen medication used in the management of prostate cancer. Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information and international supply enquiries for healthcare businesses and pharmaceutical distributors.
This guide covers Tabi Tablets' composition, medical uses, potential benefits, side effects and important safety information for readers in the United States.
Tabi Tablets – Product Information
Tabi Tablets contain Bicalutamide, an androgen receptor inhibitor that helps manage prostate cancer by blocking the effects of male hormones, particularly testosterone, on prostate cancer cells.
Available Product Strengths:
Tabi Tablets 50mg – Bicalutamide 50mg
Tabi Tablets 150mg – Bicalutamide 150mg
Drug Category: Anti-androgen / Anticancer Medicine
Dosage Form: Oral Tablets
Therapeutic Area: Oncology
Active Ingredient: Bicalutamide
Medical Uses and Benefits of Tabi Tablets
Bicalutamide works by blocking androgen receptors, reducing the ability of male hormones to stimulate prostate cancer cell growth.
Potential therapeutic benefits include:
Prostate Cancer Management: Bicalutamide 50mg is indicated in the United States in combination with a luteinizing hormone-releasing hormone (LHRH) analogue for metastatic prostate cancer.
Hormonal Action: It blocks the effects of testosterone on prostate cancer cells.
Androgen Receptor Inhibition: It helps reduce hormonal stimulation of cancer cells.
Combination Therapy: It can be used alongside other prescribed hormonal treatments as part of an oncology treatment plan.
The 150mg strength has been studied in clinical settings; however, daily bicalutamide 150mg is not FDA-approved in the United States, either as monotherapy or in combination with other treatments.
Possible Side Effects of Tabi Tablets
Like other prescription oncology medicines, Bicalutamide may cause side effects. Commonly reported reactions include:
Hot flashes and excessive sweating
Breast tenderness or enlargement
Nausea and abdominal discomfort
Weakness and fatigue
Constipation or diarrhoea
Anaemia
Swelling in the legs or ankles
Reduced sexual desire
Important Safety Information: Bicalutamide may cause serious liver injury. Patients require appropriate liver-function monitoring. Yellowing of the skin or eyes, dark urine, severe abdominal pain or unusual fatigue requires prompt medical assessment.
Patients should inform their healthcare provider about existing medical conditions and all medicines they take, particularly anticoagulants.
Tabi Tablets for the US Pharmaceutical Market
Healthcare professionals, pharmaceutical distributors and procurement organisations researching Bicalutamide tablets should verify product registration, manufacturing quality, labelling and applicable FDA requirements before purchasing or importing.
For the US market, the FDA-approved indication and dosage must be distinguished from products or strengths marketed in other countries. Product availability does not establish FDA approval.
Frequently Asked Questions (FAQs)
1. What are Tabi Tablets used for?
Tabi Tablets contain Bicalutamide, which is used in the treatment of prostate cancer under medical supervision.
2. What strengths of Tabi Tablets are available?
The product range discussed here includes 50mg and 150mg strengths.
3. What is the active ingredient in Tabi Tablets?
The active pharmaceutical ingredient is Bicalutamide.
4. Can Tabi Tablets cause side effects?
Yes. Possible side effects include hot flashes, breast tenderness, nausea, fatigue and liver-related complications.
5. Are Tabi Tablets FDA-approved in the USA?
Bicalutamide 50mg has an FDA-approved indication for use with an LHRH analogue in metastatic prostate cancer. The 150mg daily regimen is not FDA-approved.
Contact Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical company serving international pharmaceutical business enquiries.
For product specifications, manufacturing documentation, export enquiries and wholesale supply information regarding Tabi Tablets 50mg and 150mg, contact Cordium Pharmaceuticals Pvt Ltd.
Medical Disclaimer: This article is intended for educational and pharmaceutical product-information purposes only. Tabi Tablets are prescription medicines and must be used under qualified medical supervision. This content does not replace professional medical advice or establish US FDA approval or commercial availability.
Keywords
